Literature DB >> 9021901

Expression of D1 receptor mRNA in projections from the forebrain to the ventral tegmental area.

X Y Lu1, L Churchill, P W Kalivas.   

Abstract

In situ hybridization was combined with Fluoro-Gold retrograde labeling to determine if cells projecting from the forebrain to the ventral tegmental area (VTA) express D1 receptor mRNA. Cell counts were made in the prefrontal cortex, shell of the nucleus accumbens, and ventral pallidum to estimate the percentage of neurons projecting to the VTA that express D1 receptor mRNA. Retrogradely labeled cells were observed in the infralimbic and prelimbic regions of the prefrontal cortex, and up to 37% of the retrogradely labeled cells expressed D1 receptor mRNA. Double-labeled cells constituted up to 89% of retrogradely labeled neurons in the rostral shell and up to 68% in the caudal shell of the nucleus accumbens. The number of retrogradely labeled cells in the ventral pallidum that were double-labeled ranged from 13% in the rostral to less than 10% in the caudal portions. These data provide anatomical support for a role of D1 receptors in the reciprocal innervation between the forebrain and VTA.

Mesh:

Substances:

Year:  1997        PMID: 9021901     DOI: 10.1002/(SICI)1098-2396(199702)25:2<205::AID-SYN11>3.0.CO;2-X

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  34 in total

1.  Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine.

Authors:  R Ranaldi; R A Wise
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

2.  Reversal of stress-induced dendritic atrophy in the prefrontal cortex by intracranial self-stimulation.

Authors:  K Ramkumar; B N Srikumar; D Venkatasubramanian; R Siva; B S Shankaranarayana Rao; T R Raju
Journal:  J Neural Transm (Vienna)       Date:  2011-12-14       Impact factor: 3.575

Review 3.  Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes.

Authors:  William R Perlman; Cynthia Shannon Weickert; Mayada Akil; Joel E Kleinman
Journal:  J Psychiatry Neurosci       Date:  2004-07       Impact factor: 6.186

Review 4.  The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.

Authors:  David H Root; Roberto I Melendez; Laszlo Zaborszky; T Celeste Napier
Journal:  Prog Neurobiol       Date:  2015-04-06       Impact factor: 11.685

5.  Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons.

Authors:  D B Carr; S R Sesack
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

6.  Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmission.

Authors:  Tanya L Daigle; Mark J Ferris; Raul R Gainetdinov; Tatyana D Sotnikova; Nikhil M Urs; Sara R Jones; Marc G Caron
Journal:  Neuropsychopharmacology       Date:  2014-04-29       Impact factor: 7.853

7.  Males, but not females, lose tyrosine hydroxylase fibers in the medial prefrontal cortex and are impaired on a delayed alternation task during aging.

Authors:  Nioka C Chisholm; Taehyeon Kim; Janice M Juraska
Journal:  Behav Brain Res       Date:  2013-01-15       Impact factor: 3.332

Review 8.  Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress: importance for psychiatric diseases.

Authors:  Thérèse M Jay; Cyril Rocher; Maïte Hotte; Laurent Naudon; Hirac Gurden; Michael Spedding
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

9.  Dopamine enhances EPSCs in layer II-III pyramidal neurons in rat prefrontal cortex.

Authors:  Carlos Gonzalez-Islas; John J Hablitz
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

10.  Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area.

Authors:  Emanuela Argilli; David R Sibley; Robert C Malenka; Pamela M England; Antonello Bonci
Journal:  J Neurosci       Date:  2008-09-10       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.